The Bromodomain Inhibitor N-Methyl pyrrolidone Prevents Osteoporosis and BMP-Triggered Sclerostin Expression in Osteocytes

類似資料

• The Bromodomain Inhibitor <i>N</i>-Methyl pyrrolidone Prevents Osteoporosis and BMP-Triggered Sclerostin Expression in Osteocytes
  著者:: Barbara Siegenthaler, 等
  出版事項: (2018-10-01)
• The bromodomain inhibitor N-methyl pyrrolidone reduced fat accumulation in an ovariectomized rat model
  著者:: Gjoksi, Bebeka, 等
  出版事項: (2016)
• N,N Dimethylacetamide a drug excipient that acts as bromodomain ligand for osteoporosis treatment
  著者:: Ghayor, Chafik, 等
  出版事項: (2017)
• The Release of the Bromodomain Ligand N,N-Dimethylacetamide Adds Bioactivity to a Resorbable Guided Bone Regeneration Membrane in a Rabbit Calvarial Defect Model
  著者:: Siegenthaler, Barbara, 等
  出版事項: (2020)
• Fibrin Hydrogel Based Bone Substitute Tethered with BMP-2 and BMP-2/7 Heterodimers
  著者:: Karfeld-Sulzer, Lindsay S., 等
  出版事項: (2015)